Revised Diagnostic Criteria for Vogt-Koyanagi-Harada Disease: Considerations on the Different Disease Categories

American Journal of Ophthalmology

Volumn 147, Issue 2, 2009, Pages

  da Silva, Felipe Theodoro Bezerra Gaspar Carvalho ^a   Damico, Francisco Max ^a   Marin, Maria Lucia ^a   Goldberg, Anna Carla ^a   Hirata, Carlos Eduardo ^a   Takiuti, Pedro Henrique ^a   Olivalves, Edilberto ^a   Yamamoto, Joyce Hisae ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; HLA DR ANTIGEN; IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; BRAZIL; CATARACT; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; DISEASE COURSE; EYE SYNECHIA; FEMALE; HUMAN; INTRAOCULAR PRESSURE; KERATOPATHY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VOGT KOYANAGI SYNDROME;

EID: 58249105835     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2008.08.034     Document Type: Article

References (25)

1. Belfort Jr. R., Nishi M., Hayashi S., Abreu M.T., Petrilli A.M., and Plut R.C. Vogt-Koyanagi-Harada's disease in Brazil. Jpn J Ophthalmol 32 (1988) 344-347
2. Maezawa N., Yano A., Taniguchi M., and Kojima S. The role of cytotoxic T lymphocytes in the pathogenesis of Vogt-Koyanagi-Harada disease. Ophthalmologica 185 (1982) 179-186
3. Yokoyama M.M., Matsui Y., Yamashiroya H.M., et al. Humoral and cellular immunity studies in patients with Vogt-Koyanagi-Harada syndrome and pars planitis. Invest Ophthalmol Vis Sci 20 (1981) 364-370
4. Norose K., and Yano A. Melanoma specific Th1 cytotoxic T lymphocyte lines in Vogt-Koyanagi-Harada disease. Br J Ophthalmol 80 (1996) 1002-1008
5. Sugita S., Sagawa K., Mochizuki M., Shichijo S., and Itoh K. Melanocyte lysis by cytotoxic T lymphocytes recognizing the MART-1 melanoma antigen in HLA-A2 patients with Vogt-Koyanagi-Harada disease. Int Immunol 8 (1996) 799-803
6. Damico F.M., Cunha-Neto E., Goldberg A.C., et al. T-cell recognition and cytokine profile induced by melanocyte epitopes in patients with HLA-DRB1*0405-positive and -negative Vogt-Koyanagi-Harada uveitis. Invest Ophthalmol Vis Sci 46 (2005) 2465-2471
7. Goldberg A.C., Yamamoto J.H., Chiarella J.M., et al. HLA-DRB1*0405 is the predominant allele in Brazilian patients with Vogt-Koyanagi-Harada disease. Hum Immunol 59 (1998) 183-188
8. Arellanes-Garcia L., Bautista N., Mora P., Ortega-Larrocea G., Burguet A., and Gorodezky C. HLA-DR is strongly associated with Vogt-Koyanagi-Harada disease in Mexican Mestizo patients. Ocul Immunol Inflamm 6 (1998) 93-100
9. Shindo Y., Inoko H., Yamamoto T., and Ohno S. HLA-DRB1 typing of Vogt-Koyanagi-Harada's disease by PCR-RFLP and the strong association with DRB1*0405 and DRB1*0410. Br J Ophthalmol 78 (1994) 223-226
10. Moorthy R.S., Inomata H., and Rao N.A. Vogt-Koyanagi-Harada syndrome. Surv Ophthalmol 39 (1995) 265-292
11. Snyder D.A., and Tessler H.H. Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol 90 (1980) 69-75
12. Sugiura S. [Some observations on uveitis in Japan, with special reference to Vogt-Koyanagi-Harada and Behçet diseases (author's transl)]. Nippon Ganka Gakkai Zasshi 80 (1976) 1285-1326
13. Read R.W., Holland G.N., Rao N.A., et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international comittee on nomenclature. Am J Ophthalmol 131 (2001) 647-652
14. Jabs D.A., Nussenblatt R.B., and Rosenbaum J.T. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 140 (2005) 509-516
15. Jabs D.A. Improving the reporting of clinical case series. Am J Ophthalmol 139 (2005) 900-905
16. Twelfth International Histocompatibility Conference. Genetic diversity of HLA: functional and medical implications. Hum Immunol 47 (1996) 1-184
17. Chee S.P., Jap A., and Bacsal K. Spectrum of Vogt-Koyanagi-Harada disease in Singapore. Int Ophthalmol 27 (2007) 137-142
18. Beniz J., Forster D.J., Lean J.S., Smith R.E., and Rao N.A. Variations in clinical features of the Vogt-Koyanagi-Harada syndrome. Retina 11 (1991) 275-280
19. Kitamura M., Takami K., Kitaichi N., et al. Comparative study of two sets of criteria for the diagnosis of Vogt-Koyanagi-Harada's disease. Am J Ophthalmol 139 (2005) 1080-1085
20. Yamaki K., Hara K., and Sakuragi S. Application of revised diagnostic criteria for Vogt-Koyanagi-Harada disease in Japanese patients. Jpn J Ophthalmol 49 (2005) 143-148
21. Cardoso I.H., Zajdenweber M.E., Muccioli C., Fimamor L.P., and Belfort Jr. R. Applicability of the 2001 revised diagnostic criteriain Brazilian Vogt-Koyanagi-Harada disease patients. Arq Bras Oftalmol 71 (2008) 67-70
22. Rao N.A., Sukavatcharin S., and Tsai J.H. Vogt-Koyanagi-Harada disease diagnostic criteria. Int Ophthalmol 27 (2007) 195-199
23. Bouchenaki N., and Herbort C.P. The contribution of indocyanine green angiography to the appraisal and management of Vogt-Koyanagi-Harada disease. Ophthalmology 108 (2001) 54-64
24. Herbort C.P., Mantovani A., and Bouchenaki N. Indocyanine green angiography in Vogt-Koyanagi-Harada disease: angiographic signs and utility in patient follow-up. Int Ophthalmol 27 (2007) 173-182
25. Mantovani A., Resta A., Herbort C.P., et al. Work-up, diagnosis and management of acute Vogt-Koyanagi-Harada disease: a case of acute myopization with granulomatous uveitis. Int Ophthalmol 27 (2007) 105-115